• Home
  • |
  • Contact
  • Add to Favorites
  • |
  • Stay up to Date
  • |
  • Tell a Colleague
  • |
  • Send us your Feedback
Skip navigation links
HOME
ABOUT EMAS
MEETINGS
MEMBERSHIP
EDUCATION
MEDIA
PATIENTS
ARCHIVES
WHO WE ARE
PRESIDENT'S LETTER
EMAS GOVERNING BOARD
EMAS ARTICLES OF ASSOCIATION
HOW TO JOIN EMAS
EMAS CORPORATE MEMBERS
AFFILIATED SOCIETIES
CONTACT US
Scroll up
Scroll down
EMAS CONGRESS
MEETINGS & EVENTS
PRESENTATIONS FROM LONDON CONGRESS
ALL MEETINGS
MEETINGS 2009
Scroll up
Scroll down
EMAS MEMBER BENEFITS
MEMBERSHIP UPDATE FORM
MEMBERSHIP APPLICATION FORM
MEMBERSHIP RENEWAL FORM
Scroll up
Scroll down
MATURITAS JOURNAL
EDUCATIONAL LINKS
EMAS CLINICAL UPDATES
EDUCATIONAL MATERIALS
Scroll up
Scroll down
EMAS PRESS RELEASES
EXTERNAL RELATIONS
Scroll up
Scroll down
INFORMATION ABOUT MENOPAUSE
WEB RESOURCES
PARTICIPATE IN RESEARCH STUDIES
REFERRAL LISTS
Scroll up
Scroll down
PPT PRESENTATIONS
ARTICLES
MENOPAUSE BOOKS
CONFERENCE INTERVIEWS
Scroll up
Scroll down
The European Menopause and Andropause Society
  • EMAS CONGRESS
  • MEETINGS & EVENTS
  • PRESENTATIONS FROM LONDON CONGRESS
  • ALL MEETINGS
  • MEETINGS 2009

Meeting and Events 

 Presentations from London Congress  

Plenary Lectures

Monday, 18 May, 2009

An aging world- Challenges ahead
B. Lunenfeld, Israel

 

Debates

Monday, 18 May, 2009

DEBATE: PROGESTIN OR PROGESTERONE – THERE IS NO REAL DIFFERENCE
Introduction
A. Gompel, France
 
Progestin or progesterone - There is no real difference
M. Dören, Germany
 
Progesterone and progestins: There are real differences
J. Desreux, A. Béliard, E. Lifrange, J.-M. Foidart, Belgium

 

Tuesday, 19 May, 2009

DEBATE: LONG-TERM PREVENTION OF OSTEOPOROSIS STARTING AT THE
MENOPAUSE IS PREFERABLE TO LATER TARGETING OF WOMEN AT
HIGH FRACTURE RISK

Long -term prevention of osteoporosis starting at the menopause
is preferable to later targeting of women at a high fracture risk

C. Christiansen, Denmark

 

Parallel Sessions

Sunday, 17 May, 2009

PARALLEL SESSION: BREAST MANAGEMENT
Managing oestrogen deficiency after breast cancer
S. Rozenberg, C. Antoine, B. Carly, F. Liebens, Belgium

PARALLEL SESSION: OBESITY AND HEALTH IN POST-MENOPAUSAL WOMEN
Obesity-a silent killer?
R. Kaaks, Germany
 
Impact of obesity on symptoms of the menopause
M.A. Lumsden, UK
 
Management of obesity in menopause
G. Mastorakos, G. Paltoglou, Greece

PARALLEL SESSION: THE AGEING MALE - LATE ONSET HYPOGONADISM (LOH)
Safety
W. Weidner, Germany
 
ISSAM recommendations for the management of late onset hypogonadism
B. Lunenfeld, Israel

PARALLEL SESSION: HRT & BREAST CANCER RISK
Decrease in breast cancer incidence and HRT
A. Gompel, G. Plu-Bureau, France
 
What is the impact of HRT on screening
B. von Schoultz, Sweden

PARALLEL SESSION: NEW DEVELOPMENTS FOR TOMORROW
Contribution of molecular biology tools
M. Ivan, USA

PARALLEL SESSION: URO-GENITAL AGEING
Managing URO-genital atrophy
G. Samsioe, Sweden
 
Maintaining standards in surgery for female urinary incontinence
P. Riss, Austria

 

Monday, 18 May, 2009

PARALLEL SESSION: PERIMENOPAUSE
Contraception after 45
A. Szarewski, UK
 
Aetiology of premature ovarian failure
S. Vujovic, Serbia
 
Managing premature ovarian failure
N. Panay, UK

 

Tuesday, 19 May, 2009

PARALLEL SESSION: SEXUAL FUNCTION
Sexuality in older couples
M. Lachowsky, France

PARALLEL SESSION: PROFESSIONAL DEVELOPMENT IN MENOPAUSE PRACTICE - EUROPE
UK special interest training in menopause
S. Gray, UK
 
Training for menopause practice in Scandinavia
M.H. Moen, Norway

PARALLEL SESSION: CARDIOVASCULAR DISEASE
Is there really a window of opportunity?
J.C. Stevenson, UK
 
The risk of stroke in postmenopausal women receiving hormonal therapy
R.A. Lobo, USA

PARALLEL SESSION: SEXUAL HEALTH
Improving immunity in the climateric years
F. Al-Azzawi, UK
 
PARALLEL SESSION: THE MENOPAUSAL UTERUS AND OVARY
Understanding uterine bleeding
M. Rees, UK
 
Benign gynaecology after menopause
H. Retto, Portugal

 

Wednesday, 20 May, 2009

PARALLEL SESSION: OSTEOPOROSIS AND FRACTURE
Advances in non-hormonal drug therapy for fracture prevention
E. Dennison, UK
 
Vertebral body quality, effect of HRT and fracture prevention in osteoporosis
M. Brincat, J. Calleja-Agius, Y. Muscat-Baron, Malta

PARALLEL SESSION: INDIVIDUALISING THERAPY FOR CLIMACTERIC SYMPTOMS
Vasomotor symptoms
D. Sturdee, UK

Joint aches & pains: individualising therapy for climacteric symptoms
M. Gambacciani, Italy
Back to Top
EMAS Online EMAS Online

© 2008 EMAS-ONLINE.ORG KENES INTERNATIONAL